Sulzer Medica, Remaining Independent, Contemplates Zimmer Buy
This article was originally published in The Gray Sheet
Executive Summary
Acquisition of Bristol-Myers Squibb's Zimmer orthopedics business is under consideration by Sulzer Medica, but Sulzer cautions that "the purchase price and other terms of a possible transaction will play an important role in the decision," according to an Oct. 27 announcement.